Metabolic & Adipose Tissue Research Peptides

Metabolic & Adipose Tissue Research

Home/Collections/Metabolic & Adipose Tissue Research

Research-Grade Peptides

Metabolic & Adipose Tissue Research

This category groups the three compounds in the Purist range most referenced in metabolic and adipose-tissue research — the literature on energy intake, energy expenditure and lipid mobilisation. Each acts on a different pathway: incretin receptor signalling, mitochondrial output and growth-hormone release. Strictly for laboratory research use. Not for human or veterinary consumption.

99%+ Verified Purity
Independent HPLC Assay
Third-Party Lab Tested
Lyophilised & Sealed

View the 3 compounds How to choose

Purist Peptides research vials for metabolic research

3Compounds in category

99%+Minimum verified purity

HPLCIndependent assay method

3Published COAs in category

99%+ PurityThird-Party Lab TestedCOA AvailableSecure Packaging

MOTS-C

R 750

Tesamorelin

R 1,999

Mechanisms

The three mechanisms studied in metabolic research

Lipid metabolism is not a single pathway, which is why the compounds here are rarely interchangeable. Retatrutide acts on three receptors at once (GLP-1, GIP and glucagon) and is studied for satiety signalling and energy expenditure. MOTS-C is a mitochondrial-derived peptide investigated for AMPK activation and mitochondrial fat oxidation. Tesamorelin is a GHRH analogue with the strongest body of research around visceral adipose tissue specifically.

Purist Peptides research compounds in a laboratory setting

Study design

Visceral versus subcutaneous fat

Research distinguishes visceral fat — the deep abdominal fat surrounding the organs — from subcutaneous fat stored under the skin. This matters when selecting a compound: Tesamorelin is referenced specifically in visceral-fat models, while Retatrutide is studied across broader energy-balance endpoints. Study design typically holds nutrition, sleep and activity constant, because compounds of this class are investigated as one variable within a protocol rather than as substitutes for those inputs.

The range

Compounds in this category

The compounds grouped here, each with the pathway it is studied for and the protocol shape most often used.

Retatrutide

Triple-receptor agonist

A triple-receptor agonist (GLP-1 / GIP / glucagon) studied for satiety signalling, glucose homeostasis and energy expenditure. Published test reports available for both 30 mg and 60 mg presentations.

The glucagon receptor arm is what distinguishes it from dual incretin agonists in the literature

View Retatrutide

MOTS-C

Mitochondrial / AMPK

A mitochondrial-derived peptide investigated for AMPK activation, insulin sensitivity and mitochondrial fat oxidation.

A non-stimulant route to metabolic signalling, acting through AMPK rather than receptor agonism

View MOTS-C

Tesamorelin

GHRH analogue

A GHRH analogue whose best-documented research application is visceral adipose tissue, with lean-mass preservation as a secondary endpoint in the published models

View Tesamorelin

Selection

How to choose

Start from the research question, not the compound name.

If the research question is…	Start with
Satiety and energy intake is the research question	Retatrutide
Cellular energy and metabolic efficiency	MOTS-C
Visceral/abdominal fat specifically	Tesamorelin

Pre-paired

Stacks built on this category

Complete research cycles — every vial needed for the full protocol, 10% below buying the vials separately.

Fat Loss StackRetatrutide + MOTS-C — complete research cycle, 3 vials.View the stack Visceral Fat StackRetatrutide + Tesamorelin — complete research cycle, 3 vials.View the stack Metabolic Reset StackRetatrutide + NAD+ + MOTS-C — complete research cycle, 7 vials.View the stack

Independent laboratory testing of Purist Peptides research compounds

Verified quality

Tested before it ships

Published third-party test reports for Retatrutide 30 mg, Retatrutide 60 mg, Tesamorelin and MOTS-C · minimum 99% verified purity · lyophilised powder, refrigerate 2–8 °C after reconstitution · full reconstitution volumes and concentration calculations on every product page. See Quality Standards.

Retatrutide 30 mg98.81% · COA PDF MOTS-C 10 mg99.11% · COA PDF Tesamorelin 20 mg99.30% · COA PDF

See Quality Standards & all COAs

Questions

Metabolic research FAQ

Which compound is studied for satiety versus mitochondrial metabolism?

Retatrutide is referenced for satiety signalling through GLP-1, GIP and glucagon receptors. MOTS-C is studied for mitochondrial output and AMPK activation. Tesamorelin targets visceral fat via the growth-hormone axis.

What is the difference between Retatrutide and Tesamorelin?

They act on entirely separate systems. Retatrutide is a triple-receptor agonist studied for satiety and energy balance; Tesamorelin is a GHRH analogue studied specifically for visceral adipose tissue. Researchers modelling deep abdominal fat use Tesamorelin; those modelling intake and satiety use Retatrutide.

How long is a typical metabolic research cycle?

Published study lengths differ by compound and by research model. The relevant literature, reconstitution volumes and handling notes are documented on each product page.

Do these compounds work without diet and training controls?

Metabolic research does not treat them that way. Credible study models hold nutrition, sleep and activity constant so the compound is the measured variable rather than a substitute for those inputs.

How is purity verified for these compounds?

Every batch is independently third-party assayed to a minimum of 99% purity. Published test reports exist for Retatrutide (30 mg and 60 mg), Tesamorelin and MOTS-C, and batch certificates of analysis are on each product page.

Keep exploring